Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 296

1.

Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study.

Dix DB, Seibel NL, Chi YY, Khanna G, Gratias E, Anderson JR, Mullen EA, Geller JI, Kalapurakal JA, Paulino AC, Perlman EJ, Ehrlich PF, Malogolowkin M, Gastier-Foster JM, Wagner E, Grundy PE, Fernandez CV, Dome JS.

J Clin Oncol. 2018 Apr 16:JCO2017771931. doi: 10.1200/JCO.2017.77.1931. [Epub ahead of print]

PMID:
29659330
2.

Reply to B. Zhang et al.

Fernandez CV, Perlman EJ, Gastier-Foster J, Geller JI, Mullen EA, Ehrlich PF, Dome JS.

J Clin Oncol. 2018 May 10;36(14):1454-1455. doi: 10.1200/JCO.2018.78.0445. Epub 2018 Apr 3. No abstract available.

PMID:
29613833
3.

Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours.

Ma X, Liu Y, Liu Y, Alexandrov LB, Edmonson MN, Gawad C, Zhou X, Li Y, Rusch MC, Easton J, Huether R, Gonzalez-Pena V, Wilkinson MR, Hermida LC, Davis S, Sioson E, Pounds S, Cao X, Ries RE, Wang Z, Chen X, Dong L, Diskin SJ, Smith MA, Guidry Auvil JM, Meltzer PS, Lau CC, Perlman EJ, Maris JM, Meshinchi S, Hunger SP, Gerhard DS, Zhang J.

Nature. 2018 Mar 15;555(7696):371-376. doi: 10.1038/nature25795. Epub 2018 Feb 28.

PMID:
29489755
4.

Solving the Hydroxychloroquine Dosing Dilemma With a Smartphone App.

Perlman EM, Greenberg PB, Browning D, Friday RP, Miller JW.

JAMA Ophthalmol. 2018 Feb 1;136(2):218-219. doi: 10.1001/jamaophthalmol.2017.6076. No abstract available.

PMID:
29302689
5.

Topical Cidofovir for Treatment-Refractory Ocular Surface Squamous Neoplasia.

Ip MH, Robert George CR, Naing Z, Perlman EM, Rawlinson W, Coroneo MT.

Ophthalmology. 2018 Apr;125(4):617-619. doi: 10.1016/j.ophtha.2017.11.021. Epub 2017 Dec 15. No abstract available.

PMID:
29249265
6.

Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.

Fernandez CV, Mullen EA, Chi YY, Ehrlich PF, Perlman EJ, Kalapurakal JA, Khanna G, Paulino AC, Hamilton TE, Gow KW, Tochner Z, Hoffer FA, Withycombe JS, Shamberger RC, Kim Y, Geller JI, Anderson JR, Grundy PE, Dome JS.

J Clin Oncol. 2018 Jan 20;36(3):254-261. doi: 10.1200/JCO.2017.73.7999. Epub 2017 Dec 6.

7.

TCF21 hypermethylation regulates renal tumor cell clonogenic proliferation and migration.

Gooskens SL, Klasson TD, Gremmels H, Logister I, Pieters R, Perlman EJ, Giles RH, van den Heuvel-Eibrink MM.

Mol Oncol. 2018 Feb;12(2):166-179. doi: 10.1002/1878-0261.12149. Epub 2017 Dec 14.

8.

Erratum: PGBD5 promotes site-specific oncogenic mutations in human tumors.

Henssen AG, Koche R, Zhuang J, Jiang E, Reed C, Eisenberg A, Still E, MacArthur IC, Rodríguez-Fos E, Gonzalez S, Puiggròs M, Blackford AN, Mason CE, de Stanchina E, Gönen M, Emde AK, Shah M, Arora K, Reeves C, Socci ND, Perlman E, Antonescu CR, Roberts CWM, Steen H, Mullen E, Jackson SP, Torrents D, Weng Z, Armstrong SA, Kentsis A.

Nat Genet. 2017 Sep 27;49(10):1558. doi: 10.1038/ng1017-1558b. No abstract available.

PMID:
28951624
9.

Atherosclerotic Plaque Tissue: Noninvasive Quantitative Assessment of Characteristics with Software-aided Measurements from Conventional CT Angiography.

Sheahan M, Ma X, Paik D, Obuchowski NA, St Pierre S, Newman WP 3rd, Rae G, Perlman ES, Rosol M, Keith JC Jr, Buckler AJ.

Radiology. 2018 Feb;286(2):622-631. doi: 10.1148/radiol.2017170127. Epub 2017 Aug 31.

PMID:
28858564
10.

A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor.

Gadd S, Huff V, Walz AL, Ooms AHAG, Armstrong AE, Gerhard DS, Smith MA, Auvil JMG, Meerzaman D, Chen QR, Hsu CH, Yan C, Nguyen C, Hu Y, Hermida LC, Davidsen T, Gesuwan P, Ma Y, Zong Z, Mungall AJ, Moore RA, Marra MA, Dome JS, Mullighan CG, Ma J, Wheeler DA, Hampton OA, Ross N, Gastier-Foster JM, Arold ST, Perlman EJ.

Nat Genet. 2017 Oct;49(10):1487-1494. doi: 10.1038/ng.3940. Epub 2017 Aug 21.

11.

Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology Group.

Ehrlich P, Chi YY, Chintagumpala MM, Hoffer FA, Perlman EJ, Kalapurakal JA, Warwick A, Shamberger RC, Khanna G, Hamilton TE, Gow KW, Paulino AC, Gratias EJ, Mullen EA, Geller JI, Grundy PE, Fernandez CV, Ritchey ML, Dome JS.

Ann Surg. 2017 Sep;266(3):470-478. doi: 10.1097/SLA.0000000000002356.

12.

Imaging of renal medullary carcinoma in children and young adults: a report from the Children's Oncology Group.

Sandberg JK, Mullen EA, Cajaiba MM, Smith EA, Servaes S, Perlman EJ, Geller JI, Ehrlich PF, Cost NG, Dome JS, Fernandez CV, Khanna G.

Pediatr Radiol. 2017 Nov;47(12):1615-1621. doi: 10.1007/s00247-017-3926-6. Epub 2017 Jul 8.

13.

Congenital capillary proliferation of the kidney: a distinctive renal vascular lesion of childhood.

Cajaiba MM, North PE, Gong S, Dickman PS, Mroczek-Musulman E, Sauer DA, Perlman EJ.

Hum Pathol. 2017 Aug;66:59-66. doi: 10.1016/j.humpath.2017.05.018. Epub 2017 May 26.

PMID:
28554576
14.

PGBD5 promotes site-specific oncogenic mutations in human tumors.

Henssen AG, Koche R, Zhuang J, Jiang E, Reed C, Eisenberg A, Still E, MacArthur IC, Rodríguez-Fos E, Gonzalez S, Puiggròs M, Blackford AN, Mason CE, de Stanchina E, Gönen M, Emde AK, Shah M, Arora K, Reeves C, Socci ND, Perlman E, Antonescu CR, Roberts CWM, Steen H, Mullen E, Jackson SP, Torrents D, Weng Z, Armstrong SA, Kentsis A.

Nat Genet. 2017 Jul;49(7):1005-1014. doi: 10.1038/ng.3866. Epub 2017 May 15. Erratum in: Nat Genet. 2017 Sep 27;49(10 ):1558.

15.

Diagnostic Utility of Pax8, Pax2, and NGFR Immunohistochemical Expression in Pediatric Renal Tumors.

Arva NC, Bonadio J, Perlman EJ, Cajaiba MM.

Appl Immunohistochem Mol Morphol. 2017 Apr 19. doi: 10.1097/PAI.0000000000000520. [Epub ahead of print]

PMID:
28426529
16.

Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using 18F-Fluciclovine PET/CT.

Miller MP, Kostakoglu L, Pryma D, Yu JQ, Chau A, Perlman E, Clarke B, Rosen D, Ward P.

J Nucl Med. 2017 Oct;58(10):1596-1602. doi: 10.2967/jnumed.116.188375. Epub 2017 Apr 6.

PMID:
28385791
17.

Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532.

Fernandez CV, Perlman EJ, Mullen EA, Chi YY, Hamilton TE, Gow KW, Ferrer FA, Barnhart DC, Ehrlich PF, Khanna G, Kalapurakal JA, Bocking T, Huff V, Tian J, Geller JI, Grundy PE, Anderson JR, Dome JS, Shamberger RC.

Ann Surg. 2017 Apr;265(4):835-840. doi: 10.1097/SLA.0000000000001716.

18.

To the Cloud! A Grassroots Proposal to Accelerate Brain Science Discovery.

Neuro Cloud Consortium. Electronic address: jovo@jhu.edu; Neuro Cloud Consortium.

Neuron. 2016 Nov 2;92(3):622-627. doi: 10.1016/j.neuron.2016.10.033.

19.

BRAF exon 15 mutations in pediatric renal stromal tumors: prevalence in metanephric stromal tumors.

Marsden L, Jennings LJ, Gadd S, Yu M, Perlman EJ, Cajaiba MM.

Hum Pathol. 2017 Feb;60:32-36. doi: 10.1016/j.humpath.2016.09.025. Epub 2016 Oct 18.

PMID:
27769870
20.

Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group.

Ooms AH, Gadd S, Gerhard DS, Smith MA, Guidry Auvil JM, Meerzaman D, Chen QR, Hsu CH, Yan C, Nguyen C, Hu Y, Ma Y, Zong Z, Mungall AJ, Moore RA, Marra MA, Huff V, Dome JS, Chi YY, Tian J, Geller JI, Mullighan CG, Ma J, Wheeler DA, Hampton OA, Walz AL, van den Heuvel-Eibrink MM, de Krijger RR, Ross N, Gastier-Foster JM, Perlman EJ.

Clin Cancer Res. 2016 Nov 15;22(22):5582-5591. doi: 10.1158/1078-0432.CCR-16-0985. Epub 2016 Oct 4.

Supplemental Content

Loading ...
Support Center